Yifan Pharmaceutical (SHE:002019) subsidiary Sichuan Defeng Pharmaceutical won a bid in the national centralized procurement for traditional Chinese medicine.
The winning product, Ginkgo Leaf Pills, improves blood circulation and cognitive function, according to a Wednesday filing with the Shenzhen bourse.
Ginkgo Leaf Pills will be supplied under the procurement agreement from the implementation date until Dec. 31, 2027.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.